All Stories

  1. Article
    Polypharmacy & Pharmacists; Multicenter Prospective Study Demonstrates Benefits of Interventions
    Shinya Suzuki
  2. Article
    Pain accompanying photoimmunotherapy for head and neck cancer
    Shinya Suzuki
  3. Article
    Impact of lenvatinib-induced proteinuria and renal dysfunction in patients with thyroid cancer
    Shinya Suzuki
  4. Article
    Multicentre prospective observational study on community pharmacist interventions to reduce inappropriate medications
    Shinya Suzuki
  5. Article
    Needs of chemotherapy regimen checks procedure: from the survey on chemotherapy regimen checks performed by pharmacists in hospitals other than designated cancer hospitals in Japan
    Shinya Suzuki
  6. Article
    MO8-5 Planned drug holidays during treatment with lenvatinib for radioiodine-refractory differentiated thyroid cancer
    Shinya Suzuki
  7. Article
    Drug cost savings resulting from the outpatient pharmacy services collaborating with oncologists at outpatient clinics
    Shinya Suzuki
  8. Article
    Grade 3 infusion-related reaction because of cetuximab administered with 5-fluorouracil and cisplatin chemotherapy for a recurrent and metastatic head and neck cancer patient who received chlorpheniramine 5 mg, dexamethasone 13.2 mg, and aprepitant 125...
    Shinya Suzuki
  9. Article
    Impact of outpatient pharmacy interventions on management of thyroid patients receiving lenvatinib
    Shinya Suzuki
  10. Article
    Evaluation of Acute Kidney Injury Associated With Anticancer Drugs Used in Gastric Cancer in the Japanese Adverse Drug Event Report Database
    Shinya Suzuki
  11. Article
    A nationwide survey of hospital pharmacist interventions to improve polypharmacy for patients with cancer in palliative care in Japan
    Shinya Suzuki
  12. Article
    Analyses of Respiratory Depression Associated with Opioids in Cancer Patients Based on the Japanese Adverse Drug Event Report Database
    Shinya Suzuki
  13. Article
    Current Status of Adverse Events Related with Opioid Analgesics in Japan: Assessment Based on Japanese Adverse Drug Event Report Database
    Shinya Suzuki
  14. Article
    A nationwide survey of community pharmacist contributions to polypharmacy in opioid-using and non-using cancer patients in Japan
    Shinya Suzuki
  15. Article
    Impact of outpatient pharmacy services collaborating with oncologists at an outpatient clinic for outpatient chemotherapy prescription orders
    Shinya Suzuki
  16. Article
    Predictive Value of Cetuximab-Induced Skin Toxicity in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NECK
    Shinya Suzuki
  17. Article
    Impact of pharmacy collaborating services in an outpatient clinic on improving adverse drug reactions in outpatient cancer chemotherapy
    Shinya Suzuki
  18. Article
    Current status of drug vial optimization use to prevent waste associated with injectable anticancer agents
    Shinya Suzuki
  19. Article
    Comparative evaluation of a website for drug incompatibility
    Shinya Suzuki
  20. Article
    ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe
    Shinya Suzuki
  21. Article
    SPS-3Impact of clinical pharmacists collaborating with oncologists in outpatient cancer chemotherapy on cost of chemotherapy
    Shinya Suzuki
  22. Article
    Retrospective analysis of premedication, glucocorticosteroids, and H1-antihistamines for preventing infusion reactions associated with cetuximab treatment of patients with head and neck cancer
    Shinya Suzuki
  23. Article
    Opportunities to significantly reduce expenditure associated with cancer drugs
    Shinya Suzuki
  24. Article
    Evaluation of community pharmacist ability to ensure the safe use of oral anticancer agents: a nationwide survey in Japan
    Shinya Suzuki
  25. Article
    Incidence and Risk Factors of Hypomagnesemia in Head and Neck Cancer Patients Treated with Cetuximab
    Shinya Suzuki
  26. Article
    The impact of pharmacist certification on the quality of chemotherapy in Japan
    Shinya Suzuki
  27. Article
    Evaluation of the anticoagulant effect and timing of the concomitant use of S-1 and warfarin
    Shinya Suzuki
  28. Article
    P2-088Impact of pharmacist outpatient interventions on management of Lenvatinib for thyroid cancer patients
    Shinya Suzuki
  29. Article
    Places to Managing Medicines Patients Brought in Hospital: Which is Better Central Pharmacy or Hospital Wards?
    Shinya Suzuki
  30. Article
    Chemotherapy regimen checks performed by pharmacists contribute to safe administration of chemotherapy
    Shinya Suzuki
  31. Article
    P2-9-52Retrospective analysis of anti-allergy prophylaxis for infusion reactions of cetuximab in head and neck cancer patients
    Shinya Suzuki
  32. Article
    P2-9-11Retrospective analysis of emergency hospital admission due to chemoradiotherapy for head and neck cancer patients
    Shinya Suzuki
  33. Article
    ソラフェニブによる手足症候群に対する尿素配合軟膏の予防投与の有効性
    Shinya Suzuki
  34. Article
    O1-18-6CETUXIMAB INFUSION REACTIONS IN JAPANESE HEAD AND NECK CANCER PATIENTS
    Shinya Suzuki
  35. Article
    998PINCIDENCE AND RISK FACTORS OF HYPOMAGNESEMIA IN HEAD AND NECK CANCER PATIENTS TREATED WITH CETUXIMAB
    Shinya Suzuki
  36. Article
    Evaluation of the impact of a flowchart-type leaflet for cancer inpatients
    Shinya Suzuki
  37. Article
    P1-100 * SURVEY OF PHARMACISTS' INVOLVEMENT IN CANCER TREATMENT IN CANCER MEDICINE COOPERATION BASE AND GENERAL HOSPITALS
    Shinya Suzuki
  38. Article
    P1-101 * ACTUAL SITUATION AND MULTIFACTORIAL ANALYSIS OF STANDARD CANCER CHEMOTHERAPY REGIMEN USE IN JAPAN
    Shinya Suzuki
  39. Article
    O1-100 * EVALUATION OF PROPHYLACTIC TETRACYCLINES USE IN CETUXIMAB CHEMOTHERAPY FOR HEAD AND NECK CANCER
    Shinya Suzuki
  40. Article
    Survey of Pharmacists Involved in Cancer Treatment in Cancer Medicine Cooperation Base Hospitals
    Shinya Suzuki
  41. Article
    Evaluation of nausea and vomiting in radiation plus concurrent weekly cisplatin (weekly CDDP+RT) without prophylactic aprepitant in head and neck cancer
    Shinya Suzuki
  42. Article
    Risk Factor of the Hand/foot Skin Reaction Induced by Sorafenib in Patients with Advanced Hepatocellular Carcinoma
    Shinya Suzuki
  43. Article
    LB023-SUN A NON-RANDOMIZED COMPARISON OF TUBE FEEDING OF ELEMENTAL DIET AND LOW RESIDUE DIET IN HEAD AND NECK CANCER PATIENTS DURING CONCURRENT CHEMORADIOTHERAPY
    Shinya Suzuki
  44. Article
    Adherence in Use of Oral Antibiotics for Fever in Outpatient Docetaxel Chemotherapy
    Shinya Suzuki
  45. Article
    Survey on Opioid and Psychotic Use by Cancer Patients
    Shinya Suzuki
  46. Article
    Evaluation of Improvement of Adherence Following Pharmacist Intervention for Hand/Foot Skin Reactions Induced by Sorafenib
    Shinya Suzuki